Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis
Kiranj Chaudagar(University of Illinois Chicago), Akash Patnaik(Johannes Gutenberg University Mainz)
Cited by 54
Related Papers
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration
|Journal of Clinical Oncology|2020|676
Pan-cancer image-based detection of clinically actionable genetic alterations
|Nature Cancer|2020|630
Reversal of Lactate and PD-1–mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer
|Clinical Cancer Research|2023|122
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer
|ESMO Open|2022|87
Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2
|Molecular Cancer Therapeutics|2020|26